Consequently, this study was designed to investigate if CXCL14 plays a critical role in TNBC progression, by analyzing patient survival rates from human datasets, tumor growth, and metastasis from an in vivo animal model, and immune profiles in the tumor microenvironment of primary and metastatic sites using flow cytometry. The gene discussed is CXCL14; the disease is neoplasm.